1.90
-2.56%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Golden Throat Holdings Group Co
Its shares trade on HKEX under the ticker 6896.HK. It has been listed since 15 July 2015. In the fiscal year to 31 December 2025, it reported revenue of CN¥943.3m and net income of CN¥251.2m. At that date it held total assets of CN¥2.29bn and shareholders' equity of CN¥1.38bn.
Golden Throat Holdings Group Co., Ltd. engages in the manufacture and sale of pharmaceutical, healthcare food, and other products. The company is headquartered in Liuzhou, Guangxi. The company went IPO on 2015-07-15. The Company’s flagship product is Golden Throat Lozenges (OTC), which is a type of lozenge mainly designed to relieve symptoms of sore, dry throat and hoarse voice caused by acute pharyngitis. The firm's subsidiaries include Golden Throat Industrial Holdings Limited, Guangxi Golden Throat Investment Consulting Co., Ltd. and Guangxi Golden Throat Co., Ltd..
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Personal Care Products
- Listed since
- 15 Jul 2015
- Employees
- 860
- Website
- goldenthroat.com ↗
Leadership
Pay as last reported
- Ms. Peizhen JiangNon-Executive Chairman of the BoardCN¥6.0m
- Mr. Yong ZengExecutive Vice Chairman of the Board, General Manager, since 2015CN¥5.5m
- Mr. Qiang ChengChief Financial Officer, Assistant General Manager
- Mr. Jinqiang HeDeputy General Manager, Executive Director, since 2015CN¥746,000
- Mr. Jianping HuangDeputy General Manager, Executive Director, since 2015CN¥747,000
- Mr. Kexiong ZengDeputy General Manager, Executive Director, since 2015CN¥747,000
- Ms. Qing LiAssistant to General Manager and Deputy Head - Manufacturing Technology Department
- Mr. Dong WuAssistant to General Manager
- Ms. Pui Shan LeeCompany Secretary
- Mr. Jiesheng QinNon-Executive Director
- Mr. Yiqun ChengNon-Executive Independent DirectorCN¥120,000
- Mr. Hua LiNon-Executive Independent DirectorCN¥120,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Golden Throat Lozenges (OTC) is a flagship product relieving sore throat symptoms in China.
- Golden Throat Industrial Holdings Limited supports the company's manufacturing operations in Liuzhou.
- 860 full-time employees ensure stable production and sales operations in Guangxi.
Weaknesses
- The company's sole focus on throat lozenges limits product diversification in Consumer Staples.
- Liuzhou, Guangxi, is a regional city with limited international market access.
- The company's IPO in 2015 has not expanded into new markets or segments.
Opportunities
- Expanding Golden Throat Lozenges into the Health Care segment in China.
- Growing demand for healthcare food products in the Consumer Staples sector.
- Potential partnerships with Guangxi Golden Throat Co., Ltd. for market expansion.
Threats
- Competition from other pharmaceutical companies in the Chinese market.
- Regulatory changes affecting OTC products in the Health Care industry.
- Economic slowdown in Guangxi impacting consumer spending on healthcare products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.